SLC38A2 and cancer: While additional cell context-specific alterations induced by SMARCA4/2-loss may also contribute to the metabolic reprograming, our results support the pivotal role of GLUT1/SLC38A2 underlying the glutamine and OXPHOS dependency of these cancer cells.